WallStSmart
XLO

Xilio Development Inc

NASDAQ: XLO · HEALTHCARE · BIOTECHNOLOGY

$7.73
-7.34% today

Updated 2026-06-05

Market cap
$52.53M
P/E ratio
P/S ratio
0.98x
EPS (TTM)
$-2.28
Dividend yield
52W range
$6 – $13
Volume
0.0M

Xilio Development Inc (XLO) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$6.34M$43.77M
Revenue growth (YoY)+589.9%
Cost of revenue$240000.00$1.06M$1.50M$1.85M$1.90M$1.64M$1.54M
Gross profit$-240000.00$-1.06M$-1.50M$-1.85M$-1.90M$6.34M$42.23M
Gross margin100.0%96.5%
R&D$14.26M$43.91M$51.19M$59.20M$52.14M$41.21M$56.04M
SG&A$4.77M$10.65M$23.86M$29.95M$27.00M$24.78M$29.71M
Operating income$-19.03M$-54.56M$-75.04M$-89.15M$-79.13M$-60.58M$-41.98M
Operating margin-954.9%-95.9%
EBITDA$-17.07M$-53.55M$-73.55M$-87.30M$-77.23M$-58.00M$-40.44M
EBITDA margin-914.3%-92.4%
EBIT$-17.31M$-54.62M$-75.04M$-89.15M$-79.13M$-59.65M$-41.98M
Interest expense$0.00$600000.00$756000.00$927000.00$127800.00$100000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-17.31M$-55.22M$-74.30M$-87.30M$-76.40M$-58.24M$-35.04M
Net income growth (YoY)-219.0%-34.6%-17.5%+12.5%+23.8%+39.8%
Profit margin-918.0%-80.1%

Frequently asked questions

What is Xilio Development Inc's revenue?

Xilio Development Inc's trailing twelve-month revenue is $53.48M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is XLO?

In its most recent fiscal year, XLO ran a gross margin of 96.48%, an operating margin of -95.92%, and a net margin of -80.05%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does XLO generate?

XLO produced $-5.51M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is XLO's balance sheet healthy?

XLO holds $137.53M in cash and equivalents against — in long-term debt, on $35.27M of shareholder equity. That debt is best read against the cash flow the business throws off each year.